Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention

Heart and Vessels

Volumn 23, Issue 2, 2008, Pages 75-82

  Ozer, Nihat ^a,c   Tangurek, Burak ^a   Firat, Fatih ^a   Ozer, Songul ^a   Tartan, Zeynep ^a   Ozturk, Recep ^a   Ozay, Batuhan ^a   Ciloglu, Figen ^b   Yilmaz, Hale ^a   Cam, Nese ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GenLab Genetic Medical Laboratories Istanbul   (Turkey)

^c NONE   (Turkey)

Author keywords

Acute coronary syndrome; Bare metal stent; Drug eluting stent; High sensitivity C reactive protein; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; DEXAMETHASONE; FIBRINOGEN RECEPTOR ANTAGONIST; INTERLEUKIN 6; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INFLAMMATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS; SYSTEMIC DISEASE; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEXAMETHASONE; DRUG-ELUTING STENTS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; METALS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41949122803     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-007-1020-y     Document Type: Article

References (39)

1. Patti G, D'Ambrosio A, Dobrina A, Dicuonzo G, Giansante C, Fiotti N, Abbate A, Guarnirei G, Di Sciascio G (2002) Interleukin-1 receptor antagonist: A sensitive marker of instability in patients with coronary artery disease. J Thromb Thrombolysis 14:139-143
2. Patti G, D'Ambrosio A, Mega S, Giorgi G, Zardi EM, Zardi DM, Dicuonzo G, Dobrina A, Di Sciascio G (2004) Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. J Am Coll Cardiol 43:35-38
3. Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A, Dobrina A (2002) Inflammatory markers and coronary interventions: A potentially useful follow-up modality after stenting. Catheter Cardiovasc Interventions 56:341-345
4. Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A, Dobrina A (2002) Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention. Am J Cardiol 89:372-376
5. Liu X, Huang Y, Hanet C, Vandormael M, Legrand V, Dens J, Vandenbossche JL, Missault L, Vrints C, De Scheerder I (2002) Study of anti-restenosis with the Biodivysio dexamethasone-eluting stent (STRIDE) - a multicenter trial (abstract). Eur Heart J 4:265
6. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, Constantini CR, Guermonprez JL, Eltchaninoff H, Blanchard D, Bartorelli A, Laarman G-J, Perin M, Sousa JE, Schuler G, Molnar F, Guagliumi G, Colombo A, Ban Hayashi E, Wülfert E, BPharm (2005) Maintenance of long-term clinical benefit with sirolimuseluting coronary stents. Three year results of the RAVEL Trial. Circulation 111:1040-1044
7. Braunwald E (1989) Unstable angina: A classification. Circulation 80:410-414
8. Di Sciascio G, Cowley MJ, Goudreau E, Vetrovec GW, Johnson DE (1994) Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: In vivo evidence of thrombosis, ulceration and inflammation. Am Heart J 128:419-426
9. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343:915-922
10. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R (1999) Pathology of acute and chronic coronary stenting in humans. Circulation 99:44-52
11. Carter AJ, Laird JR, Kufs WM, Bailey L, Hoopes TG, Reeves T, Farb A, Virmani R (1996) Coronary stenting with a novel stainless steel balloon expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model. J Am Coll Cardiol 27:1270-1277
12. Van Beusekom HMM, Van der Geissen WJ, Van Suylen RJ, Bos E, Bosman FT, Serruys PW (1993) Histology after stenting of human saphenous vein bypass grafts: Observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 21:45-54
13. Pietersma A, Kofflard M, de Wit LE, Stijnen T, Koster JF, Serruys PW, Sluiter W (1995) Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 91:1320-1325
14. Bennett MR (2003) In-stent restenosis: Pathology and implication for the development of drugs eluting stents. Heart 89:218-224
15. Bhatia V, Bhatia R, Dhindsa M (2004) Drug-eluting stents: New era and new concerns. Postgrad Med J 80:13-18
16. Yasojima K, Schwab C, McGeer EG, McGeer PL (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158:1039-1051
17. Bhakdi S, Tarzewski M, Klouche M, Hemmes M (1999) Complement and atherogenesis: Binding of CRP to degraded non-oxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 19: 2348-2354
18. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrio A, Chiariello L, Gioffre PA (1998) Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 82:515-518
19. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, Zorn G, Glogar D, Probst P, Maurer G, Huber K (2000) Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 21:1152-1158
20. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, Wu AH, Waters DD (1997) Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80:1476-1478
21. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA (2000) Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 85:92-95
22. Angioi M, Abdelmouttaleb I, Rodriguez RM, Aimone-Gastin I, Adjalla C, Gueant JL, Danchin N (2001) Increased C-reactive protein levels in patients with in-stent restenosis and its implications. Am J Cardiol 87:1189-1193
23. Stone GW, Ellis SG, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, for the TAXUS-IV Investigators (2004): A polymerbased, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231
24. Patti G, Pasceri V, Carminati P, D'Ambrosio A, Carcagni A, Di Sciascio G (2005) Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 95:502-505
25. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, Ghini AS, Ferrero V, Chiariello L, Gioffrè PA, Romeo F, Crea F (2002) Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 40:1935-1942
26. Tunon MJ, Sanchez-Campos S, Gutierrez B, Culebras JM, Gonzales-Gallego J (2003) Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes. Biochem Pharmacol 66:439-445
27. Jackson JK, Tudan C, Sahl B, Pelech SL, Burt HM (1997) Calcium pyrophosphate dihydrate crystals activate MAP kinase, oxidase activation and degranulation responses of neutrophils by Taxol. Immunology 90:502-510
28. Marx SO, Marks AR (2001) Bench to bedside: The development of rapamycin and its application to stent restenosis. Circulation 104:852-855
29. Roberts RL, Nath J, Friedman MM, Gallin JL (1982) Effects of Taxol on human neutrophils. J Immunol 129:2134-2141
30. Longhenecker JP, Kilty LA, Johnson LK (1984) Glucocorticoid inhibition of vascular smooth muscle cell proliferation: Influence of homologous extracellular matrix and serum mitogens. J Cell Biol 98:534-540
31. MacDonald RG, Panush RS, Pepine CJ (1987) Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 60(suppl): 56B-60B
32. Kereiakes DJ (2003) Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: The role of modulating inflammation. Circulation 108(suppl III):III-22-III-27
33. Kanadasi M, Cayli M, Demirtas M, Inal T, Demir M, Koc M, Avkarogullari M, Dönmez Y, Usal A, Alhan CC, San M (2006) The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. Heart Vessels 21(5):291-297
34. De la Torre-Hernandez JM, Sainz-Laso F, Burgos V, Perez T, Figueroa A, Zueco J, Colman T (2005) Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents. Am J Cardiol 95:748-751
35. Caixeta AM, Brito FS, Costa MA, Serrano CV, Petriz JL, Da Luz PL (2007) Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. Catheter Cardiovasc Interv 69(4):500-507
36. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, Holecki M, Kumor P (2006) Inflammatory markers in a 2-year follow-up of coronary artery disease. Heart Vessels 21(5):302-308
37. Zhang Q, Lu L, Pu L, Zhang R, Shen J, Zhu Z, Hu J, Yang Z, Chen Q, Shen W (2007) Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine. Cardiovasc Diabetol 6:16
38. Jaffe R, Strauss BH (2007) Late and very late thrombosis of drugeluting stents evolving concepts and perspectives. J Am Coll Cardiol 50(2):119-127
39. Daemen J, Tanimoto S, Garcia-Garcia HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW (2007) Comparison of three-year clinical outcome of sirolimus-and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99(8):1027-1032